← FDA DRUG APPROVALS

FDA ANDA · ANDA085353

THEOCLEAR-100

Sponsor: CENT PHARMS

APPLICATION
ANDA085353
TYPE
ANDA
ORIGINAL APPROVAL
1980-08-11
LATEST ACTION
1980-08-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

THEOCLEAR-100Discontinued
THEOPHYLLINE 100MG · TABLET · ORAL
THEOCLEAR-200Discontinued
THEOPHYLLINE 200MG · TABLET · ORAL

Approval history

1980-08-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →